ANDA 88842, held by Pharmaderm. Hydrocortisone.
As of Nov 14, 2026, ANDA 88842 (Hydrocortisone), held by Pharmaderm, was first approved by FDA on Feb 9, 1987, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 9, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrocortisone1% ยท ointment;topical | Hydrocortisone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
